3//SEC Filing
Q-Ventures Program II (Co-Invest Holdings) Ltd. 3
Accession 0000899243-19-025488
CIK 0001706431other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 9:23 PM ET
Size
7.3 KB
Accession
0000899243-19-025488
Insider Transaction Report
Form 3
Holdings
Series B Convertible Preferred Stock
→ Common Stock (555,555 underlying)Series A-1 Convertible Preferred Stock
→ Common Stock (1,111,111 underlying)
Footnotes (2)
- [F1]The Series A-1 Convertible Preferred Stock is convertible (i) at any time at the option of the holder; (ii) automatically upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended (the "Securities Act"), resulting in gross proceeds to the Issuer of not less than $200 million; or (iii) by vote or written consent of the holders of at least 60% of the then outstanding shares of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (voting together as a single class), in the case of (i) into fully paid and nonassessable shares of Common Stock on a 1-for-1 basis, subject to certain adjustments for dilution, if any, resulting from future stock issuances, and in the case of (ii) and (iii) into fully paid and nonassessable shares of Common Stock at the then-effective conversion rate for such share.
- [F2]The Series B Convertible Preferred Stock is convertible (i) at any time at the option of the holder; (ii) automatically upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in gross proceeds to the Issuer of not less than $200 million; or (iii) by vote or written consent of the holders of at least 60% of the then outstanding shares of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (voting together as a single class), in the case of (i) into fully paid and nonassessable shares of Common Stock on a 1-for-1 basis, subject to certain adjustments for dilution, if any, resulting from future stock issuances, and in the case of (ii) and (iii) into fully paid and nonassessable shares of Common Stock at the then-effective conversion rate for such share.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001790363
Filing Metadata
- Form type
- 3
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 9:23 PM ET
- Size
- 7.3 KB